# Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeting-the-mir-221-222-puma-bak-bax-pathway-abrogates-dexamethasone/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jianjun Zhao,Zhang‐Bo Chu,Yiguo Hu,Jianhong Lin,Zhongqiu Wang,Meng Jiang,Ming Chen,Xujun Wang,Yue Kang,Yangsheng Zhou,Tríona Ní Chonghaile,Melanie Johncilla,Yu‐Tzu Tai,Jin Q. Cheng,Antony Letai,Nikhil C. Munshi,Kenneth C. Anderson,Ruben D. Carrasco |
| Citations | 91 |
| DOI | 10.1158/0008-5472.can-15-0457 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2145637287 |
| PMID | 26249174 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Meng Jiang](https://scholariq.org/researchers/meng-jiang/)

## Paper journal

- [Cancer Research](https://scholariq.org/journals/cancer-research/)

## Paper primary topic

- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

## Paper topics

- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.